文献速递肿瘤 PET/CT

孤立性淋巴结淀粉样变性:系列18F-FDG PET/CT扫描评估化疗疗效

Isolated Lymph Node Amyloidosis: Response Assessment to Chemotherapy on Serial 18F-FDG PET/CT Scans.
PubMed 文献 · Clin Nucl Med · 2020-01-01

本文报告一例50岁男性淋巴结病患者的病例,活检及血清游离轻链检测确诊为孤立性淋巴结淀粉样变性,无其他器官受累。使用18F-FDG PET/CT系列扫描评估硼替佐米、环磷酰胺和地塞米松化疗后的疗效。

要点

  • 孤立性淋巴结淀粉样变性无其他器官受累在临床中极为罕见。
  • 由于影像学表现非特异,该病诊断极具挑战性。
  • 18F-FDG PET/CT可用于评估该病对硼替佐米、环磷酰胺和地塞米松方案的疗效。

核心结论

  • 本例为50岁男性淋巴结病,活检及血清游离轻链检测确诊为孤立性淋巴结淀粉样变性,18F-FDG PET/CT有效用于评估硼替佐米、环磷酰胺和地塞米松的疗效。

研究设计与样本

  • 病例报告,报告一例50岁男性淋巴结病患者。

主要发现

  • 患者表现为淋巴结病,活检及血清游离轻链检测确诊为淀粉样变性。
  • 18F-FDG PET/CT系列扫描用于评估对硼替佐米、环磷酰胺和地塞米松的疗效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Amyloidosis is a disorder resulting from the deposition of fibrillary protein in the extracellular tissue and can be classified into primary, secondary, familial, and senile types. Isolated lymph node amyloidosis without any other organ involvement is very rarely seen in clinical parlance, and diagnosis remains very challenging owing to nonspecific imaging findings. We present a case of 50-year-old man with lymphadenopathy, which was later confirmed to be amyloidosis on biopsy and serum-free light chain assay with efficacious use of F-FDG PET/CT for response assessment to bortezomib, cyclophosphamide, and dexamethasone.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Tripathy S, Bharadwaj M, Prakash S, et al. Isolated Lymph Node Amyloidosis: Response Assessment to Chemotherapy on Serial 18F-FDG PET/CT Scans. Clin Nucl Med. 2020. PMID: 32604112. doi:10.1097/RLU.0000000000003156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。